Quarterlytics / Healthcare / Biotechnology / NervGen Pharma Corp. Common stock

NervGen Pharma Corp. Common stock

NGEN · NASDAQ Healthcare
Claim this profile
Ticker NGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Employees 7
Overview Research & Coverage Annual Reports FAQ Peers Earnings Calls Financials News Management

Business description

NervGen Pharma Corp. is a clinical-stage biotechnology company developing therapies aimed at treating nerve damage and neurodegenerative conditions by targeting mechanisms that inhibit nervous system repair.

West Vancouver, BC
Is this your company?
Claim profile to control your coverage, no call required.
Company facts
TickerNGEN
ExchangeNASDAQ
Sector Healthcare
Industry Biotechnology
Employees7